Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
681 innovaTV 207 Parts E and F: a phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress)
Compose a Response to This Article
Other responses
No responses have been published for this article.
